Maraviroc
NDC 72319-025, Maraviroc, tablet, film coated, from i3 Pharmaceuticals, LLC.
- Product NDC
- 72319-025
- Status
- Listed
- Labeler
- i3 Pharmaceuticals, LLC
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA217114
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/72319-025 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- MARAVIROC300 mg/1
Pharmacologic classes
CCR5 Co-receptor Antagonist [EPC]; Chemokine Co-receptor 5 Antagonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 72319-025-02 | 72319002502 | 60 TABLET, FILM COATED in 1 BOTTLE (72319-025-02) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/f7b9c67b-10c6-45b5-b2a8-952cd350b0b1NADAC price for package 72319002502
GET /v1/drugs/nadac/72319002502
Use it
Look up 72319-025 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/72319-025 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 72319-025. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.